Dengue fever vaccine (DHF) can now be obtained in Indonesia, after it was introduced several years ago. Although still in the final stages of clinical trials, the use of DHF vaccine is highly recommended to reduce the number of DHF cases in Indonesia.
At present the DHF vaccine has received approval from the Food and Drug Supervisory Agency (BPOM), as of December 2016.
Considered Effective and Safe
Dengue fever is one of the deadliest diseases for countries with tropical and subtropical climates, including Indonesia. DHF cases occur in all provinces and have increased every year. Data from the Indonesian Ministry of Health noted that in 2015, there were more than 120 thousand dengue cases. DHF vaccine actually just entered phase III of the four phases of clinical trials. However, the effectiveness and safety of this vaccine are considered sufficient. This vaccine can reduce the risk of hospitalization and the risk of severe DHF, and there is no evidence of dangerous side effects. DHF viruses have four variants called serotypes namely DEN-1, DEN-2, DEN-3, and DEN-4. DHF vaccine is still recommended despite having been exposed to this disease before. Because, there is still the possibility of DHF infection from different serotypes. By giving the vaccine, the body will form immunity against other virus serotypes that have never transmitted infections.Instructions for Use of DHF Vaccine
The dengue fever vaccine is intended for children and adults from ages 9-45 years. However, the benefits of providing vaccines have proven to be more effective for ages 9-15. The following instructions for use and dose of dengue vaccine:- Vaccine dose is given three times as much as 0.5 mL with an injection interval of six months.
- If the vaccine is delayed then a doctor's consultation is needed to determine the change in schedule.
- Dengue vaccine shots are given subcutaneously (the lower layer of the skin) in the upper arm of the deltoid region.
- Pregnant and nursing mothers.
- Have a history of severe allergic reactions to the contents of the DHF vaccine or other vaccines with the same content.
- Delay the vaccine if you have moderate or severe fever.
- Patients with HIV infection both symptomatic (with symptoms) and asymptomatic (without symptoms).
Comments
Post a Comment